Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?

T E Ichim, Z Zhong, N A Mikirova, J A Jackson, R Hunninghake, E Mansilla, G Marín, L Núñez, A N Patel, N Angle, M P Murphy, C A Dasanu, D T Alexandrescu, V Bogin, N H Riordan

Journal: Panminerva medica 2011;52(2 Suppl 1):75-80

PMID: 20657539

Abstract

To provide an overview of molecular and cellular processes involved in erectile dysfunction (ED) with emphasis on circulating endothelial progenitor cells (EPC) and discuss possible nutraceutical means of intervention. A review of literature on Pubmed related to EPC and ED was conducted. Patients with ED appear to possess a reduced number of circulating EPC, which is associated with poor endothelial function possibly as a result of underlying low-grade inflammation. Several studies support the possibility of improving erectile function by inhibition of inflammation as well as administration of various stem cell types. One particularly interesting approach is nutraceutical supplementation to increase circulating EPC, as demonstrated in the product Stem-Kine. Interventions aimed at increasing circulating EPC may have potential in treatment of vascular ED.

Address: Department of Urology, Medistem Inc, San Diego, CA 92121, USA. [email protected]

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.